SLC5A2 and type 2 diabetes mellitus: This study investigated the impact of SGLT2 inhibitors on patients with diabetic ketoacidosis, revealing a higher prevalence of euglycemic ketoacidosis in LADA and an increased incidence of genitourinary infections, particularly among female patients.